Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment

BACKGROUND: Up to a fifth of patients diagnosed with prostate cancer (PC) will develop castration-resistant prostate cancer (CRPC), which has been associated with a poor prognosis. The aim of this study was to consider the patient perspective as part of the overall treatment decision-making process...

Descripción completa

Detalles Bibliográficos
Autores principales: Uemura, Hiroji, Matsubara, Nobuaki, Kimura, Go, Yamaguchi, Akito, Ledesma, Dianne Athene, DiBonaventura, Marco, Mohamed, Ateesha F., Basurto, Enrique, McKinnon, Ian, Wang, Ed, Concialdi, Kristen, Narimatsu, Aya, Aitoku, Yasuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095997/
https://www.ncbi.nlm.nih.gov/pubmed/27814714
http://dx.doi.org/10.1186/s12894-016-0182-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095997/
https://www.ncbi.nlm.nih.gov/pubmed/27814714
http://dx.doi.org/10.1186/s12894-016-0182-2

Ejemplares similares